Core Laboratories (CLB) Tops Q4 EPS by 1c, Offers Q1 Guidance

Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $156.8 million versus the consensus estimate of $156.04 million.

GUIDANCE:

Core Laboratories sees Q1 2020 EPS of $0.39-$0.41, versus the consensus of $0.39. Core Laboratories sees Q1 2020 revenue of $159-164 million, versus the consensus of $159.4 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
• Endava CFO placed on leave amid accounting probe